ALPS【ALPS】銘柄情報

ALPS Group Inc (ALPS) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.7175

( 1.06% )

買値

0.68

売値

0.72

出来高

10,499

0.68 日の範囲 0.734

0.1425 52 週間の範囲 1.75

時価総額

119.392M

前日終値

0.71

始値

0.734

時刻

0.7199

最終取引時間

05:06:21

財務取引量

US$ 7,379

VWAP

0.702814

平均取引量 (3 か月)

US$ 33,664

発行済株式数

166,400,326

配当利回り

PER

-15.6

1 株当たり利益 (EPS)

-0.05

歳入

3.74M

純利益

-2.64M

Alps Group Inc, a biotechnology company, provides research and development, medical services, and wellness solutions for advanced therapies. The company is based in Kuala Lumpur, Malaysia. Alps Group Inc, a biotechnology company, provides research and development, medical services, and wellness solutions for advanced therapies. The company is based in Kuala Lumpur, Malaysia.

セクター

業界

ウェブサイト

alps-holdings.com

本社

Kuala Lumpur, Malaysia

設立

ALPS Group Inc is listed in the sector of the ナスダック市場 with ticker ALPS. The last closing price for ALPS was US$0.71. Over the last year, ALPS shares have traded in a share price range of US$ 0.1425 to US$ 1.75.

ALPS currently has 166,400,326 shares in issue. The market capitalisation of ALPS is US$119.39 million. ALPS has a price to earnings ratio (PE ratio) of -15.60.

Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

KUALA LUMPUR, Malaysia, May 19, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the...

Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight

KUALA LUMPUR, Malaysia, April 17, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”...

Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol

KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the...

Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy

KUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the...

Alps Announces Closing of Business Combination with Globalink Investment Inc.

KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0125	-1.71232876712	0.73	0.767	0.6565	79031	0.70884542	CS
4	-0.0825	-10.3125	0.8	0.92	0.635	44889	0.75067306	CS
12	-0.2968	-29.2615596963	1.0143	1.245	0.635	24245	0.82993892	CS
26	-0.4625	-39.1949152542	1.18	1.39	0.635	39785	0.95358175	CS
52	0.575	403.50877193	0.1425	1.75	0.1425	101759	1.05079748	CS
156	0.1175	19.5833333333	0.6	1.75	0.14	66461	0.72314786	CS
260	-4.2825	-85.65	5	6.18	0.14	72670	0.88720171	CS